Sirpiglenastat (Synonyms: DRP-104) |
| Catalog No.GC69896 |
Sirpiglenastat (DRP-104) is a broad-spectrum glutamine antagonist. Sirpiglenastat has anti-cancer effects by directly targeting tumor metabolism and inducing effective anti-tumor immune responses at the same time.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2079939-05-0
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Sirpiglenastat
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Sirpiglenastat
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *